Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury
- PMID: 31860794
- PMCID: PMC10613510
- DOI: 10.1056/NEJMsr1915313
Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury
Figures




References
-
- Layden J, Ghinai I, Pray I, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin — preliminary report. N Engl J Med 2019. Sep 6. - PubMed
-
- Lozier MJ, Wallace B, Anderson K, et al. Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, December 2019. MMWR Morb Mortal Wkly Rep 2019;68:1142–1148. - PMC - PubMed
-
- Centers for Disease Control and Prevention. Severe pulmonary disease associated with using e-cigarette products. Health Alert Network. August 30, 2019. CDCHAN-00421. https://emergency.cdc.gov/han/han00421.asp.
-
- Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products: Dates of symptom onset and hospital admission for patients with lung injury associated with e-cigarette use, or vaping — United States, March 31–November 16, 2019. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-d....
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical